SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...

Scott Weiner will moderate a discussion on the current IPO market at BIO International Convention 2013 in Chicago.
News | 04. 22. 2013
Scott Weiner will moderate a discussion on the current IPO market at BIO International Convention 2013 in Chicago.